stella
beta
Combined HAIC, Lenvatinib and Pucotenlimab As Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma — Stella
Recruiting
Back to Cholangiocarcinoma Non-resectable trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei
View full record on ClinicalTrials.gov